Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMedicolegalClass-action suit filed against insurer for breast imaging chargesThe lawsuit alleges Oscar Health Insurance required policyholders to pay deductibles and coinsurance for diagnostic breast imaging in violation of Texas law.Womens ImagingAI model predicts breast cancer risk in diverse populationCTUltralow-dose CT leads to less radiation in osteoporosis patientsAIClairity deploys AI for breast cancer risk predictionSponsor ContentRegister today for our June 17 webinar
